Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-25 @ 4:07 AM
NCT ID:
NCT00001020
Eligibility Criteria:
Inclusion Criteria
Patients must have:
* Documented HIV seronegativity.
* Good general health.
* No high-risk behavior for HIV infection.
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms or conditions are excluded:
* Postive PPD (unless a chest x-ray is negative and there is no suggestion of active or old pulmonary tuberculosis).
* Positive VDRL or HBsAG.
* No febrile illness within 1 week of study.
Concurrent Medication:
Excluded:
* Concomitant corticosteroids or other known immunosuppressive drugs.
* Other experimental agents.
Patients with the following prior conditions are excluded:
* History of clinically significant cardiac, pulmonary, hepatic, renal, neurologic, or autoimmune disease.
Prior Medication:
Excluded:
* Other immunization within 4 weeks prior to study entry.
Identifiable high-risk behavior for HIV infection.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00001020
Study Brief:
Protocol Section:
NCT00001020